Market

Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use Declined

Outset Medical First-Quarter Results Demonstrate Strong Growth in Console and Recurring Revenue as Gross Margin Expanded and Cash Use Declined
Read More

Related Posts

SpaceX may be worth more than half of Tesla — with a sixth of the revenue

SpaceX may be worth more than half of Tesla — with a si...

Here’s how the best investors protect their money from market bubbles and FOMO

Here’s how the best investors protect their money from ...

Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares for $75,400

Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares...

Enanta Pharma chief medical officer sells $11k in stock

Enanta Pharma chief medical officer sells $11k in stock

Adaptive Biotechnologies CSO Robins sells $672,515 in ADPT stock

Adaptive Biotechnologies CSO Robins sells $672,515 in A...

Enanta Pharma chief product officer sells $30k in stock

Enanta Pharma chief product officer sells $30k in stock